Choose your country site
Close

Expert Opinion

Ayming’s consultants share their expertise and opinions.

Home > Insights > Expert Opinion
page-hero

Q&A: My internship at Ayming with Jamie

We caught up with Jamie Earl, a Senior Consultant in our R&D tax incentives team, to ask him about his…
More
Q&A: My internship at Ayming with Penny
We caught up with Penny Sherlock, an Associate Consultant in our R&D tax incentives team. Penny joined us in 2019…
More
Q&A: My internship at Ayming with Penny
What lessons can we learn from vaccine R&D process?
The world has breathed a collective sigh of relief. After nine months of waiting, vaccines are inbound. The recent announcements…
More
What lessons can we learn from vaccine R&D process?
UK’s net-zero goal relies on R&D in construction
The UK aims to achieve net-zero carbon emissions by 2050, yet, at the same time has pledged to build more…
More
UK’s net-zero goal relies on R&D in construction
Monthly digest with Mark Smith – December 2020
Let’s look forward to 2021 As the saying goes, diamonds can’t be made without pressure, and the entire world has…
More
Monthly digest with Mark Smith – December 2020
Month in focus: November 2020
November 2020 A selection of the month’s news stories curated by the team at Ayming, along with their expert insights.…
More
Month in focus: November 2020
Monthly digest with Mark Smith – November 2020
Preventing abuse of the R&D Tax Credit scheme On 12th November, the Government published an updated version of its consultation…
More
Monthly digest with Mark Smith – November 2020

Preventing abuse of the R&D Tax Credit scheme

The consultation on preventing abuse of HMRC’s R&D Tax Credit scheme was originally published in March of this year and…
More
3D bioprinting – The next step in tailor-made medicine
From aerospace components to complete building structures, 3D printing technologies are at the forefront of innovation across a range of industries.…
More
3D bioprinting – The next step in tailor-made medicine
Psychedelic drugs and mental health – A breakthrough treatment?
The use of psychedelic drugs to treat mental illnesses is nothing new, it was first introduced over 70 years ago…
More
Psychedelic drugs and mental health – A breakthrough treatment?
Monthly digest with Mark Smith – October 2020
Rising numbers of R&D tax claims but Government must do more This year’s numbers show a continuation of the strong…
More
Monthly digest with Mark Smith – October 2020
Month in focus: September 2020
September 2020 A selection of the month’s news stories curated by the team at Ayming, along with their expert insights.…
More
Month in focus: September 2020
Sustainable life sciences – A return to nature
We’re noticing a shift in focus within Life Sciences research. A movement away from fossil fuels and petrochemical plastics, and…
More
Sustainable life sciences – A return to nature
Smoothing the road ahead for automotive supply chains
It is no secret that the automotive industry plays a key part in the global economy. Some 92.8 million motor…
More
Smoothing the road ahead for automotive supply chains